Pet Meds and Supplements Market
Request Sample Report
Pet Meds and Supplements Market Size and Growth
The Pet Meds and Supplements market is experiencing significant growth, driven by rising pet ownership and increasing consumer awareness of pet health. The global market size is projected to reach approximately $20 billion by 2025, with a CAGR of around 8%. The demand for natural and preventive care products is particularly prominent.
Companies Covered
(Covid 19 Impact Covered)
◍ Boehringer Ingelheim
◍ Ceva Sante Animale
◍ Bimeda Animal Health
◍ Dechra Pharmaceuticals
◍ Zoetis
◍ Merck
◍ Elanco
◍ Bayer
◍ Boehringer
◍ Novartis
◍ Virbac
◍ Ceva
◍ Vetoquinol
◍ Nexvet
◍ Aratana Therapeutics
◍ Kindred Biosciences
◍ Ambrx
◍ Entest Biomedical
The Pet Meds and Supplements Market features major players like Zoetis, Merck, and Elanco. Companies focus on innovative products, research, and strategic partnerships to expand their offerings. Notable revenues include Zoetis ($8 billion), Merck ($2.3 billion), and Elanco ($1.8 billion), driving market growth through effective marketing and distribution strategies.
Request Sample Report
Market Segmentation
By Application
Dogs
Cats
Rabbit
Bird
Other
Request Sample Report
By Product
External Use
Oral Use
Market Growth
Request Sample Report
$ X Billion USD
